文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Distributional Cost-Effectiveness Analysis Comes of Age.

作者信息

Cookson Richard, Griffin Susan, Norheim Ole F, Culyer Anthony J, Chalkidou Kalipso

机构信息

Centre for Health Economics, University of York, York, England, UK.

Centre for Health Economics, University of York, York, England, UK.

出版信息

Value Health. 2021 Jan;24(1):118-120. doi: 10.1016/j.jval.2020.10.001. Epub 2020 Nov 7.

DOI:10.1016/j.jval.2020.10.001
PMID:33431145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7813213/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedd/7813213/b4c007fbcde1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedd/7813213/b4c007fbcde1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedd/7813213/b4c007fbcde1/gr1.jpg

相似文献

[1]
Distributional Cost-Effectiveness Analysis Comes of Age.

Value Health. 2021-1

[2]
Medical electronics: buy now.

Med Device Technol. 2003-6

[3]
The need for independent physics advice.

Eur J Nucl Med Mol Imaging. 2003-4

[4]
Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.

Health Technol Assess. 2015-2

[5]
Equity in national healthcare economic evaluation guidelines: Essential or extraneous?

Soc Sci Med. 2024-9

[6]
NICE, social values, and balancing objectivity and equity.

Pharmacoeconomics. 2014-11

[7]
Objectivity and equity: clarity required. A response to Hill and Olson.

Pharmacoeconomics. 2014-12

[8]
Recent amendments to NICE's value-based assessment of health technologies: implicitly inequitable?

Expert Rev Pharmacoecon Outcomes Res. 2017-6

[9]
Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project.

Health Technol Assess. 2013-12

[10]
Methodological issues in undertaking independent cost-effectiveness analysis for NICE: the case of therapies for ADHD.

Eur J Health Econ. 2008-5

引用本文的文献

[1]
Stakeholders' Perceptions of the Nature-Based Healing Industry in South Korea: A Q Methodology Study.

Healthcare (Basel). 2025-8-14

[2]
The Impact of Alteplase Coverage on Health Equity for the Treatment of Ischemic Stroke in the USA: A Distributional Cost-Effectiveness Analysis.

Appl Health Econ Health Policy. 2025-7-1

[3]
Using Linked Health Service Data in Multimodal Modeling of Kidney Transplant Waitlist Outcomes: Protocol for the Maximizing Organ Donor Utility Systemwide (MODUS) Study.

JMIR Res Protoc. 2025-7-29

[4]
Protocol for the economic evaluation of the Care for Adolescents who Received Information 'Bout Outcomes, 2nd iteration (CARIBOU-2) non-randomised, cluster-controlled trial of an integrated care pathway for depression in adolescents.

BMJ Open. 2025-5-15

[5]
Application of distributional cost-effectiveness analysis methodology in real-world studies: a scoping review protocol.

BMJ Open. 2025-5-12

[6]
Distributional Cost-Effectiveness Analysis in Genomic Medicine: Considerations for Addressing Health Equity.

Value Health. 2025-5-6

[7]
Policy models for preventative interventions in cardiometabolic diseases: a systematic review.

BMC Health Serv Res. 2025-5-2

[8]
Social determinants of where people die: A study of moderators and mediators using linked UK Census and mortality data.

SSM Popul Health. 2025-3-21

[9]
Decision-Analytical Modelling of Medicines in the Middle East: A Systematic Review of Economic Evaluation Studies.

Appl Health Econ Health Policy. 2025-4-12

[10]
Using natural experiments to evaluate population health and health system interventions: new framework for producers and users of evidence.

BMJ. 2025-3-28

本文引用的文献

[1]
COVID-19 Pandemic, Unemployment, and Civil Unrest: Underlying Deep Racial and Socioeconomic Divides.

JAMA. 2020-7-21

[2]
To include or not include: renal dialysis policy in the era of universal health coverage.

BMJ. 2020-1-28

[3]
Aggregate Distributional Cost-Effectiveness Analysis of Health Technologies.

Value Health. 2019-5

[4]
Evaluation of Intervention Impact on Health Inequality for Resource Allocation.

Med Decis Making. 2019-2-28

[5]
Distributional cost-effectiveness analysis in low- and middle-income countries: illustrative example of rotavirus vaccination in Ethiopia.

Health Policy Plan. 2018-4-1

[6]
CONSORT-Equity 2017 extension and elaboration for better reporting of health equity in randomised trials.

BMJ. 2017-11-23

[7]
Using Cost-Effectiveness Analysis to Address Health Equity Concerns.

Value Health. 2017-2

[8]
Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial.

Pharmacoeconomics. 2016-9

[9]
Cardiovascular screening to reduce the burden from cardiovascular disease: microsimulation study to quantify policy options.

BMJ. 2016-6-8

[10]
A new proposal for priority setting in Norway: Open and fair.

Health Policy. 2016-3

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索